Rogers【ROG】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

103.20

買値

売値

出来高

4,540

102.51 日の範囲 103.93

96.10 52 週間の範囲 138.855

時価総額

1.926B

前日終値

102.58

始値

103.93

時刻

103.13

最終取引時間

00:23:21

財務取引量

US$ 469,100

VWAP

103.3259

平均取引量 (3 か月)

130,743

発行済株式数

18,660,557

配当利回り

PER

34.11

1 株当たり利益 (EPS)

3.03

歳入

939.8M

純利益

56.6M

Rogers Corporation designs develop and manufacture engineered materials and components for sale to original equipment manufacturers and component suppliers. The firm operates in three business segments: advanced connectivity solutions, which manufactures circuit materials for applications in communi... Rogers Corporation designs develop and manufacture engineered materials and components for sale to original equipment manufacturers and component suppliers. The firm operates in three business segments: advanced connectivity solutions, which manufactures circuit materials for applications in communications infrastructure, automotive, and consumer electronics markets; elastomeric material solutions, which provide cushioning, sealing, and impact protection in automotive, transportation, and construction applications; and power electronics solutions, which sells ceramic substrate materials for power module applications. The firm generates revenue primarily in the United States, China, and Germany, but has a presence around the world. 詳細を表示

セクター

Plastics,resins,elastomers

業界

Plastics,resins,elastomers

ウェブサイト

www.rogerscorp.com

本社

Boston, Massachusetts, USA

設立

Rogers Corp is listed in the Plastics,resins,elastomers sector of the ニューヨーク証券取引所 with ticker ROG. The last closing price for Rogers was US$102.58. Over the last year, Rogers shares have traded in a share price range of US$ 96.10 to US$ 138.855.

Rogers currently has 18,660,557 shares in issue. The market capitalisation of Rogers is US$1.91 billion. Rogers has a price to earnings ratio (PE ratio) of 34.11.

Roche receives CE Mark for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first IHC-based companion diagnostic to identify ovarian cancer patients eligible for ELAHERE

Roche receives CE Mark for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first IHC-based companion diagnostic to identify ovarian cancer patients eligible for ELAHERE PR Newswire TUCSON, Ariz...

Roche receives FDA approval for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY

Roche receives FDA approval for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY PR...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-1.2	-1.14942528736	104.4	104.73	100.02	145070	103.06551168	CS
4	1.57	1.54481944308	101.63	114.05	96.1	152122	104.02385227	CS
12	-4.56	-4.23162583519	107.76	114.05	96.1	130743	104.26735043	CS
26	-15.63	-13.1532441303	118.83	134.065	96.1	137891	111.81561385	CS
52	-28.32	-21.5328467153	131.52	138.855	96.1	142893	115.35393064	CS
156	-166.94	-61.7975864367	270.14	274.51	96.1	214677	173.04413646	CS
260	-25.77	-19.9813910212	128.97	274.51	75.72	177705	170.03252992	CS

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
CTVInnovid Corp	US$ 3.0289 (86.97%)	34.62M
SNOWSnowflake Inc	US$ 168.49 (30.49%)	21.32M
ODVOsisko Development Corporation	US$ 1.8147 (22.61%)	637.6k
LEVLion Electric Company	US$ 0.2192 (16.60%)	501.62k
UTIUniversal Technical Institute Inc	US$ 23.12 (16.24%)	358.39k
CATOCato Corp	US$ 4.87 (-19.90%)	84.8k
CLCOCool Company LTD	US$ 9.15 (-14.00%)	704.47k
CPACCementos Pacasmayo SAA New	US$ 5.81 (-11.16%)	15.64k
ZIMZIM Integrated Shipping Services Ltd	US$ 24.065 (-10.90%)	5.44M
CPACopa Holdings SA	US$ 95.325 (-9.91%)	351.35k
CTVInnovid Corp	US$ 3.0289 (86.97%)	34.62M
SNOWSnowflake Inc	US$ 168.49 (30.49%)	21.32M
PLTRPalantir Technologies Inc	US$ 62.73 (0.98%)	16.84M
IONQIonQ Inc	US$ 30.55 (5.86%)	13.16M
NIONIO Inc	US$ 4.645 (-0.11%)	12.12M